Mendoza, Abdel Azis .
HRN: 21-47-01 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
AMPICILLIN 250MG (VIAL)
06/16/2022
06/16/2022
IVTT
85mg
Q12
Prematurity
Waiting Final Action
06/21/2022
CEFTAZIDIME 1GM (VIAL)
06/21/2022
06/27/2022
IVTT
85
Q12
Neonatal Sepsis
Waiting Final Action
06/18/2023
CEFUROXIME 750MG (VIAL)
06/18/2023
06/25/2023
IV
260mg
Q8
Sepsis
Waiting Final Action